Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ELOVL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FIP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBCE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIPRL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IER5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UHMK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927137 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPDL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JADE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL21R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A43 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OTUD7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on